April 2017 in “European Psychiatry” This study found that females treated with atypical anti-psychotics had a higher prevalence of probable polycystic ovarian syndrome compared to normal controls.
November 2007 in “Hospital pharmacy” This article discusses the importance of increasing awareness about specific adverse drug reactions, prevention methods, and the promotion of reporting ADRs to the FDA's MEDWATCH program; it reports no new results.
23 citations
,
April 2017 in “Clinical, Cosmetic and Investigational Dermatology” This review discusses the importance of recognizing and treating psychiatric conditions in dermatology patients, offering practical recommendations for dermatologists to manage psychocutaneous diseases effectively, but reports no new clinical results.
19 citations
,
February 2007 in “International Clinical Psychopharmacology” This study provided the first published case reports of alopecia associated with the use of quetiapine.
9 citations
,
October 2012 in “Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology” This case report describes hair loss associated with olanzapine use, which resolved after discontinuation of the drug, highlighting potential reversible alopecia with atypical antipsychotics.